Navigation Links
Clostridium difficile Infection: Current Challenges and Controversies
Date:1/20/2009

in the provision of quality healthcare and is dedicated to offering professionals meaningful opportunities for lifelong learning," says President and CEO, Robert M. Colleluori.

RMEI is a medical education company that specializes in independent, accredited, and nonaccredited education. The goal of all accredited RMEI educational offerings is to promote a spirit of lifelong learning and continuous professional development. RMEI works closely with medical experts to design activities that improve diagnosis and treatment. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.rmei.com.


'/>"/>
SOURCE Robert Michael Educational Institute LLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Medarex and Massachusetts Biologic Laboratories Announce Primary Objective Achieved in Phase 2 Trial of Monoclonal Antibody Combination for the Treatment of Clostridium difficile Associated Diarrhea (CDAD)
2. Putting a new spin on current research
3. New small-scale generator produces alternating current by stretching zinc oxide wires
4. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
5. Huifeng Bio-Pharmaceutical (HFGB) Provides Update on Current Business and COS Certification
6. 72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds
7. Avastin Used in Combination with Drugs from Bristol-Myers Squibb Has Advantages in Survival Rates Over the Current Sales-Leading Therapy for Advanced Ovarian Cancer
8. Anavex 7-1037 reduces rate of cancer tumor growth 69% in pre-clinical studies, compared to currently marketed drug Dacarbazine showing no measurable activity
9. National Stem Cell Holding, Inc. Has Engaged BMA Securities to Assist and Advise the Company With Its Current Capital Raise of $3,500,000
10. GlaxoSmithKline Consumer Healthcare Recommends Maintaining FDAS Current Two-Class Drug System
11. First New Class of Platinum-Based Chemotherapy Drug Candidates in 30 Years Demonstrate Ability to Kill Tumors Resistant to Currently Marketed Platinum Drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... (PRWEB) May 27, 2015 The Academy of ... join in celebrating National Model Aviation Day. The third annual ... was created to celebrate the model aviation hobby nation-wide and ... all of its approximately 2,350 chartered clubs to celebrate the ... event in their communities. There will also be a local ...
(Date:5/27/2015)... , May 27, 2015 /CNW/ - CQDM, Brain ... close to $8.5M to six (6) multi-disciplinary and multi-provincial ... neuroscience within their Focus on Brain strategic initiative. To ... entities involved as in-kind contributions. This exciting announcement was ... Association for Neuroscience in the presence of Inez Jabalpurwala, ...
(Date:5/27/2015)... The ALS Therapy Development Institute announced ... Anelixis Therapeutics , $1.5 million toward the development ... innate immune system. The funding comes from the $4 ... 2014 social media phenomenon known as the “ALS Ice ... directly by the Institute through last year’s Ice Bucket ...
(Date:5/27/2015)... SOUTH SAN FRANCISCO, Calif. , May 27, ... therapeutics for the treatment of cancer, today announced ... chief financial officer and Cynthia Ladd ... to joining CytomX, Goeltz was chief financial officer ... previously served as an independent consultant and legal ...
Breaking Biology Technology:Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 2Academy of Model Aeronautics Foundation to host National Model Aviation Day Motorcycle Rally and Family Fest in Muncie, IN 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 2Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 3Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 4Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 5Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 6Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 7Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 8Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 9Focus on Brain: $10M for breakthrough technologies to address unmet needs in neurosciences 10Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 2Ice Bucket Challenge Advances Antibody Toward Clinical Trial for ALS 3CytomX Expands Executive Leadership Team 2CytomX Expands Executive Leadership Team 3
... April 9 ThromboGenics NV,(Euronext Brussels: THR), a ... cancer, announces today that it has completed,patient enrolment ... primary purpose of,this study is to evaluate the ... to acute stroke patients,between four and twelve hours ...
... Tapestry,Pharmaceuticals, Inc. (Nasdaq: TPPH ) today announced ... Stock Market ("Nasdaq") formally notifying it that,Nasdaq has ... ended January,2, 2008, as required by Marketplace Rule ... stock will be suspended. Tapestry,does not intend to ...
... ShapeGrabber and Nikon,Instruments Inc. today announced an ... distribution channel in the United States for ... systems. This arrangement will,increase ShapeGrabber,s current distribution ... to provide customers with,additional non-contact solutions to ...
Cached Biology Technology:ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 2ThromboGenics Completes Patient Enrolment of MITI IV Trial, a Phase II Study Evaluating the Safety and Preliminary Efficacy of Microplasmin in the Treatment of Acute Stroke 3Tapestry Receives Nasdaq Delisting Notice 2ShapeGrabber and Nikon Instruments Inc. Announce Distribution Agreement 2
(Date:5/18/2015)... May 18, 2015 Fingerprint Cards (FPC) ... FPC1025, FPC1145, FPC1155 and FPC1035 from one if its module ... and including Q3 2015 and the sensors will be used ... order values for 2015 hereby amount to 740 MSEK to ... of 140 MSEK and a number of smaller orders not ...
(Date:5/14/2015)... 14, 2015  Verificient Technologies, Inc., a ... online remote proctoring, announced a new alliance ... and creator of the Canvas Learning Management ... companies will benefit from the seamless integration ... As a fully integrated multifactor biometrics behavioral ...
(Date:5/11/2015)... DAYTON, Ohio , May 11, 2015  Through a ... Ohio had a strong showing at AUVSI,s ... . These representatives of Ohio,s UAS ... domestic and abroad from all points along the UAS ecosystem. ... Dayton Development Coalition,s (DDC) Vice President for Aerospace Rich ...
Breaking Biology News(10 mins):Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2Verificient and Instructure Announce Alliance Partnership to Provide Online Proctoring for K-12 and Higher Education Institutions 2Ohio Flies High at Unmanned '15, Sets Stage for Ohio UAS Conference 2
... at Toronto General Hospital have discovered the 'SOS' distress signal ... to the injured heart after a heart attack. , While ... the ability to clear the dead tissue after a heart ... critically important role of bone marrow adult stem cells in ...
... Therapeutics announced today that it has succeeded in developing ... that, for the first time, puts avian transgenics on ... announcement in conjunction with the publication of an article ... the University of California, Davis on its transgenic technology ...
... for fruit and vegetables has been developed, which quite ... could be used in place ozone-depleting chemicals, like methyl ... , The technique, called metabolic stress disinfection (MSDD), ... University of California, Davis (Journal of the Science of ...
Cached Biology News:A surprise about our body clock 2A surprise about our body clock 3Origen publishes in Nature a robust and versatile method for creating transgenic chickens 2Origen publishes in Nature a robust and versatile method for creating transgenic chickens 3
... ,This solution greatly enhances antigen-antibody reactions, yielding ... with conventional methods. ,Two kinds of solution ... which can suppress the background and increase ... ,It is applicable to various assay system ...
Mouse Anti-Human Killer Cell Immunoglobulin-like Receptor, Two Domains, Long Cytoplasmic Tail, 2 (KIR2DL2 (KIR2DL3 Monoclonal Antibody Family: Immunoglobulin Sub-Family: not assigned-Immunogl...
pH-dependent fluorescence; Maximum intensity observed in basic solutions....
Mouse anti human pro-Relaxin-2...
Biology Products: